A Prospective Study of Natural History and Clinical Outcomes for Basilar Invagination

Sponsor
Xuanwu Hospital, Beijing (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05909540
Collaborator
(none)
200
1
28.7
7

Study Details

Study Description

Brief Summary

A Prospective Study of Natural History and Clinical Outcomes for Basilar Invagination

Condition or Disease Intervention/Treatment Phase
  • Procedure: Posterior facet distraction and fusion

Detailed Description

Since basilar invagination was reported, its pathogenesis has been considered both primary and secondary. Surgical treatment methods emerged in an endless stream, and a hundred schools of thought contend. However, the link between the symptoms and imaging has not been studied in detail. We prospectively enrolled patients with basilar depression, and then explored the natural history of the disease and the clinical outcomes of early intervention.

Study Design

Study Type:
Observational
Anticipated Enrollment :
200 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
A Prospective Study of Natural History and Clinical Outcomes for Basilar Invagination
Actual Study Start Date :
Feb 6, 2022
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Jun 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Goel A Type Basilar Invagination

1) ADI>3mm in adults, or ADI>5mm in child.

Procedure: Posterior facet distraction and fusion
With the patient in prone position, cervical traction was only intraoperatively after anesthesia with weights of approximately 5-8 kg during surgery. Monitoring of the spinal cord with motor evoked potential and somatosensory evoked potential were used throughout the surgery. Using a posterior midline incision, the occiput to the C2 spinous process was surgically exposed, separated to the lateral edge of the C1-2 joint, and cut off at the C2 nerve root to expose the C1-2 articular surface Quantitative reduction techniques included the following steps .1) Facet joint release and cage implantation technique 2)Adjusting POCA by cantilever and occipitocervical fixation technique.

Goel B Type Basilar Invagination

ADI<3mm in adults, or ADI<5mm in child. The stabilization in atlantoaxial could can be found. The tip of odontoid can exceed the Chamberlian's line, but not exceed the Wackenheim's line and Mcrae's line.

Procedure: Posterior facet distraction and fusion
With the patient in prone position, cervical traction was only intraoperatively after anesthesia with weights of approximately 5-8 kg during surgery. Monitoring of the spinal cord with motor evoked potential and somatosensory evoked potential were used throughout the surgery. Using a posterior midline incision, the occiput to the C2 spinous process was surgically exposed, separated to the lateral edge of the C1-2 joint, and cut off at the C2 nerve root to expose the C1-2 articular surface Quantitative reduction techniques included the following steps .1) Facet joint release and cage implantation technique 2)Adjusting POCA by cantilever and occipitocervical fixation technique.

Outcome Measures

Primary Outcome Measures

  1. improved symptoms [1 months postoperatively]

    The symptoms improved after the opration or natural condition.(JOA scores and SF-12 scores)

  2. improved symptoms [3 months postoperatively]

    The symptoms improved after the opration or natural condition.(JOA scores and SF-12 scores)

  3. improved symptoms [6 months postoperatively]

    The symptoms improved after the opration or natural condition.(JOA scores and SF-12 scores)

  4. improved radiology [1 months postoperatively]

    improved ADI, CCA, CTA ; The basilar invagination reduced

  5. improved radiology [3 months postoperatively]

    improved ADI, CCA, CTA ; The basilar invagination reduced

  6. improved radiology [6 months postoperatively]

    improved ADI, CCA, CTA ; The basilar invagination reduced

  7. operation complication [1 months postoperatively]

    operation complication(Excessive bleeding, bronchopneumonia, vertebral artery injury )

  8. operation complication [3 months postoperatively]

    operation complication(Excessive bleeding, bronchopneumonia, vertebral artery injury )

  9. operation complication [6 months postoperatively]

    operation complication(Excessive bleeding, bronchopneumonia, vertebral artery injury )

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. BI discovered by the patient not incidentally;

  2. Patients with depression of the skull base caused by congenital skeletal developmental malformations and symptoms;

  3. The patient was initially treated in our center, and the interval between onset and treatment was at least 1 month or no treatment;

  4. The imaging diagnosis of BI meets the standard (3-5mm higher than the Chamberlain's line)

Exclusion Criteria:
  1. secondary BI caused by trauma, pathological factors such as rheumatoid arthritis, hyperparathyroidism, osteogenesis imperfecta, rickets, osteomalacia, spinal cord tumors, tuberculosis, inflammation of adjacent structures, and simple AAD, odontoid body deformity, etc.

  2. spinal vascular disease, intervertebral disc herniation, tethered spinal cord disease and other diseases that may cause symptoms.

  3. Patients with incomplete imaging data or symptomatic data.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Xuanwu Hospital, Capital Medical University Beijing China 100053

Sponsors and Collaborators

  • Xuanwu Hospital, Beijing

Investigators

  • Principal Investigator: Zan Chen, MD. PHD., Xuanwu Hospital, Beijing

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Xuanwu Hospital, Beijing
ClinicalTrials.gov Identifier:
NCT05909540
Other Study ID Numbers:
  • XW-NS-PNHBI
First Posted:
Jun 18, 2023
Last Update Posted:
Jun 18, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 18, 2023